This is consistent with the findings of studies on NOTCH1 in colorectal cancer, ovarian cancer, breast cancer, and hematological malignancies (27, 38–40), indicating that upregulated expression of NOTCH1 may be one of the signals of poor prognosis across different types of cancers. The gene discussed is NOTCH1; the disease is breast carcinoma.